» Articles » PMID: 34742250

Major Adverse Cardiovascular Event Definitions Used in Observational Analysis of Administrative Databases: a Systematic Review

Overview
Publisher Biomed Central
Date 2021 Nov 7
PMID 34742250
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Major adverse cardiovascular events (MACE) are increasingly used as composite outcomes in randomized controlled trials (RCTs) and observational studies. However, it is unclear how observational studies most commonly define MACE in the literature when using administrative data.

Methods: We identified peer-reviewed articles published in MEDLINE and EMBASE between January 1, 2010 to October 9, 2020. Studies utilizing administrative data to assess the MACE composite outcome using International Classification of Diseases 9th or 10th Revision diagnosis codes were included. Reviews, abstracts, and studies not providing outcome code definitions were excluded. Data extracted included data source, timeframe, MACE components, code definitions, code positions, and outcome validation.

Results: A total of 920 articles were screened, 412 were retained for full-text review, and 58 were included. Only 8.6% (n = 5/58) matched the traditional three-point MACE RCT definition of acute myocardial infarction (AMI), stroke, or cardiovascular death. None matched four-point (+unstable angina) or five-point MACE (+unstable angina and heart failure). The most common MACE components were: AMI and stroke, 15.5% (n = 9/58); AMI, stroke, and all-cause death, 13.8% (n = 8/58); and AMI, stroke and cardiovascular death 8.6% (n = 5/58). Further, 67% (n = 39/58) did not validate outcomes or cite validation studies. Additionally, 70.7% (n = 41/58) did not report code positions of endpoints, 20.7% (n = 12/58) used the primary position, and 8.6% (n = 5/58) used any position.

Conclusions: Components of MACE endpoints and diagnostic codes used varied widely across observational studies. Variability in the MACE definitions used and information reported across observational studies prohibit the comparison, replication, and aggregation of findings. Studies should transparently report the administrative codes used and code positions, as well as utilize validated outcome definitions when possible.

Citing Articles

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug-eluting stents: A multicenter real-world study.

Wilairat P, Phrommintikul A, Chotayaporn T, Wattanasombat S, Hmuenpha R, Kornjirakasemsan S Chronic Dis Transl Med. 2025; 11(1):57-68.

PMID: 40051818 PMC: 11880128. DOI: 10.1002/cdt3.154.


Predictive model development combining CT-FFR and SYNTAX score for major adverse cardiovascular events in complex coronary artery disease.

Luo W, Li C, Yan G, Huang Z, Yue Y, Yang D Sci Rep. 2025; 15(1):7152.

PMID: 40021816 PMC: 11871039. DOI: 10.1038/s41598-025-91708-3.


Impact of non-participation bias due to psychiatric illness on mortality and cardiovascular event estimates: a Danish longitudinal population study.

Rygner Z, Ellervik C, Rasmussen M, Torp-Pedersen C, Poulsen H, Jorgensen A BMJ Public Health. 2025; 2(1):e000289.

PMID: 40018250 PMC: 11812749. DOI: 10.1136/bmjph-2023-000289.


Association of Opioid Prescription with Major Adverse Cardiovascular Events: Nationwide Cohort Study.

Oh T, Cho H, Song I J Clin Med. 2025; 14(4).

PMID: 40004734 PMC: 11855939. DOI: 10.3390/jcm14041205.


Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.

Kritchevsky S, Zamora E, Bhasin S, Cohen A, Chandler A, Covinsky K Res Sq. 2025; .

PMID: 39989956 PMC: 11844647. DOI: 10.21203/rs.3.rs-5920485/v1.


References
1.
Kiss Z, Rokszin G, Abonyi-Toth Z, Jermendy G, Kempler P, Aradi D . Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary. Cardiovasc Diabetol. 2018; 17(1):107. PMC: 6062985. DOI: 10.1186/s12933-018-0751-7. View

2.
Arinze N, Farber A, Sachs T, Patts G, Kalish J, Kuhnen A . The effect of statin use and intensity on stroke and myocardial infarction after carotid endarterectomy. J Vasc Surg. 2018; 68(5):1398-1405. DOI: 10.1016/j.jvs.2018.02.035. View

3.
Hsu C, Chen Y, Huang P, Leu H, Su Y, Chiang C . The association between urinary calculi and increased risk of future cardiovascular events: A nationwide population-based study. J Cardiol. 2015; 67(5):463-70. DOI: 10.1016/j.jjcc.2015.07.016. View

4.
Giral P, Neumann A, Weill A, Coste J . Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France. Eur Heart J. 2019; 40(43):3516-3525. PMC: 6855142. DOI: 10.1093/eurheartj/ehz458. View

5.
Korsnes J, Davis K, Ariely R, Bell C, Mitra D . Health care resource utilization and costs associated with nonfatal major adverse cardiovascular events. J Manag Care Spec Pharm. 2015; 21(6):443-50. PMC: 10401973. DOI: 10.18553/jmcp.2015.21.6.443. View